FN2 Earnings Intelligence
Roivant Sciences Ltd. ratios (quarterly)
Roivant Sciences Ltd. (ROIV) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 12/31/2025 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,238.5 | $1,237 | $1,478.3 | $1,248.5 | $1,642.3 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2.2 | $1.6 | $2 | $1.4 | $35.1 | $37.8 | $66.1 |
| % Growth | -96.1% | -64.9% | -77.8% | -33.5% | 2,135.6% | 1,792.5% | - |
| Gross Profit | - | - | - | - | $31.8 | - | - |
| % Margin | - | - | - | - | 90.5% | - | - |
| EBITDA | -$283.8 | - | - | -$365.4 | - | - | - |
| % Margin | -13,079.4% | - | - | -25,339.3% | - | - | - |
| Net Income | -$223.4 | -$113.5 | -$265.9 | -$189.8 | -$191.6 | - | - |
| % Margin | -10,292.9% | -7,225.9% | -13,301.2% | -13,164.8% | -545.6% | - | - |
| Diluted EPS | -$0.33 | -$0.17 | -$0.38 | -$0.26 | -$0.27 | -$0.31 | -$0.31 |
| % Growth | -375.0% | 45.2% | -265.2% | 21.2% | -58.8% | 18.9% | - |
| Operating Cash Flow | -$204.4 | - | - | -$270.5 | - | - | - |
| CapEx | $4 | - | - | $0.4 | - | - | - |
| Free Cash Flow | -$208.4 | - | - | -$270.9 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 12/31/2025 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2 | $1.6 | $2 | $1.4 | $35.1 | $37.8 | $66.1 |
| Gross Profit | - | - | - | - | $31.8 | - | - |
| EBITDA | -$283.8 | - | - | -$365.4 | - | - | - |
| Net Income | -$223.4 | -$113.5 | -$265.9 | -$189.8 | -$191.6 | - | - |
| Diluted EPS | -$0.33 | -$0.17 | -$0.38 | -$0.26 | -$0.27 | -$0.31 | -$0.31 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 12/31/2025 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,238.5 | $1,237 | $1,478.3 | $1,248.5 | $1,642.3 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 12/31/2025 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$204.4 | - | - | -$270.5 | - |
| Capital Expenditure | $4 | - | - | $0.4 | - |
| Free Cash Flow | -$208.4 | - | - | -$270.9 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 12/31/2025 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | -96.1% | -64.9% | -77.8% | -33.5% | 2,135.6% |
| Gross Margin | - | - | - | - | 90.5% |
| EBITDA Margin | -13,079.4% | - | - | -25,339.3% | - |
| Net Margin | -10,292.9% | -7,225.9% | -13,301.2% | -13,164.8% | -545.6% |
| FCF Margin | -9,604.5% | - | - | -18,788.0% | - |
| Diluted EPS Growth | -375.0% | 45.2% | -265.2% | 21.2% | -58.8% |
Get the ROIV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.